샘플 요청 목록

 카트 문의
시장보고서
상품코드
1886061

세계의 면역혈액학 분석기 및 시약 시장

Immunohematology Analyzers and Reagents
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 179 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 면역혈액학 분석기 및 시약 시장은 2030년까지 33억 달러에 달할 전망

2024년에 25억 달러로 추정되는 세계의 면역혈액학 분석기 및 시약 시장은 2024년부터 2030년까지의 분석 기간 동안 CAGR 4.7%로 성장하여 2030년까지 33억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석 대상으로 한 부문 중 하나인 시약은 4.2%의 CAGR을 기록하며 분석 기간 종료까지 23억 달러에 달할 것으로 예측됩니다. 분석기 부문의 성장률은 분석 기간 동안 5.8%의 CAGR로 추정됩니다.

미국 시장은 6억 7,880만 달러로 추정되는 한편 중국은 CAGR 4.5%로 성장할 것으로 예측됩니다

미국의 면역혈액학 분석기 및 시약 시장은 2024년에 6억 7,880만 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2024년부터 2030년까지의 분석 기간 동안 CAGR 4.5%를 기록하며 2030년까지 5억 1,900만 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다가 있으며, 각각 분석 기간 동안에 CAGR 4.3%, 3.9%로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 4.7%의 CAGR로 성장할 것으로 예측됩니다.

세계의 면역혈액학 분석기 및 시약 시장 - 주요 시장 동향과 촉진요인 개요

면역혈액학 분석기 및 시약은 어떻게 안전한 수혈을 보장할 수 있을까?

면역혈액학 분석기 및 시약은 수혈 의학 분야에서 매우 중요하며, 수혈의 안전성과 적합성을 보장하는 데 핵심적인 역할을 하고 있습니다. 이러한 첨단 장비와 화학제품은 혈액형, Rh 인자, 수혈 시 부작용을 일으킬 수 있는 특정 항체의 존재 여부 등 중요한 마커를 검사하는 데 사용됩니다. 예를 들어, 혈액형 판정은 헌혈자와 수혈자의 적합성을 판단하는 데 매우 중요합니다. 면역혈액학 분석기는 이 과정을 자동화하여 적혈구 표면의 항원(A형, B형, RhD 등)을 검출 및 식별함으로써 의료진이 헌혈 혈액과 수혈자의 면역체계와의 적합성을 정확하게 판단할 수 있도록 돕습니다.

면역혈액학 시약은 혈액형 판정 외에도 과거 수혈, 임신 또는 자가면역질환으로 인해 형성될 수 있는 비정상적인 항체를 확인하는 데도 사용됩니다. 이러한 항체는 수혈 전에 검출되지 않으면 용혈 반응을 일으킬 수 있습니다. 이 반응은 신체가 수혈된 적혈구를 공격하여 생명을 위협하는 합병증을 유발할 수 있습니다. 응집 반응, 효소면역측정법(ELISA), 마이크로 컬럼 겔 기술과 같은 첨단 면역학 기술을 통해 분석기는 미량의 항체도 정확하게 검출합니다. 신속하고 정확한 자동 검사를 제공하는 면역혈액학 분석기 및 시약은 수혈의 안전과 성공을 보장하고, 응급상황과 일상적인 임상 현장 모두에서 궁극적으로 생명을 구하는 역할을 하고 있습니다.

면역혈액학 분석기 및 시약이 질병 검출 및 혈액 관리에서 매우 중요한 이유는 무엇인가?

면역혈액학 분석 기기와 시약은 수혈의 안전성을 넘어 중요한 역할을 담당하고 있습니다. 혈액 관련 질환의 진단과 면역 및 혈액 시스템에 영향을 미치는 질환의 관리에도 필수적입니다. 가장 중요한 응용 분야 중 하나는 신생아 용혈성 질환(HDN)의 검출 및 관리입니다. 이 질환은 산모의 항체가 태아의 적혈구를 공격하여 빈혈 및 기타 합병증을 유발하는 질환입니다. 전문 면역혈액학 시약을 사용하여 의료진은 항D 항체 및 기타 관련 마커를 검출할 수 있으며, Rh 면역글로불린 투여를 통한 HDN 예방과 같은 조기 개입 및 치료를 가능하게 합니다.

면역혈액학 기술은 자가면역성 용혈성 빈혈 관리에서도 매우 중요한 역할을 합니다. 이 질환은 면역체계가 적혈구를 잘못 파괴하는 질환입니다. 이 시스템은 환자의 혈액을 공격하는 자가 항체를 식별하여 면역 억제 요법이나 적합한 수혈 등 적절한 치료 방침을 결정하는 데 도움을 줍니다. 또한, 골수 이식과 같은 복잡한 의료 시술에서는 이식 세포가 숙주의 몸을 공격할 수 있는 이식편대숙주질환을 피하기 위해 이러한 분석기를 통한 정확한 혈액 적합성 검사가 매우 중요합니다.

또한, 면역혈액학 시약은 만성 빈혈이나 화학요법을 받는 암 환자 등 장기 치료 중인 환자의 경과 관찰에도 사용됩니다. 면역 기능과 혈액의 전반적인 건강 상태를 평가하기 위해서는 정기적인 혈액 검사가 필수적입니다. 면역혈액학 분석기를 통한 자동화는 지속적인 질병 관리에 필수적인 높은 처리량과 정밀한 결과를 보장합니다. 면역학 및 혈액학 질환의 복잡성이 증가함에 따라 이러한 시스템은 임상의에게 필수적인 도구가 되어 다양한 혈액 질환의 효과적인 진단, 모니터링 및 관리를 돕고 있습니다.

면역혈액학 분석기는 실험실의 기술 혁신을 어떻게 촉진하고 있는가?

면역혈액학 분석기는 검사실 자동화의 최첨단에 위치하며, 워크플로우의 효율성과 검사 정확도를 향상시켜 혈액은행 및 임상 검사실 운영 방식을 혁신하고 있습니다. 이 분야의 주요 발전 중 하나는 면역혈액학 시스템에 자동화 및 로봇 공학을 통합하여 혈액 샘플의 높은 처리량을 처리할 수 있게 된 것입니다. 현대식 분석기는 최소한의 인위적 개입으로 하루 수백 개의 시료를 처리할 수 있어 인적 오류의 위험을 줄이고 표준화된 검사 절차를 보장합니다. 이는 혈액제제에 대한 수요가 지속적으로 증가하고, 신속하고 신뢰할 수 있는 결과가 환자 치료에 필수적인 대형 병원과 혈액은행에서 특히 중요합니다.

면역혈액학 분석기에 첨단 소프트웨어 및 데이터 관리 도구가 내장된 것도 실험실의 효율성을 혁신적으로 변화시켰습니다. 이들 시스템은 현재 병원 정보 시스템(HIS) 및 검사정보관리 시스템(LIMS)과의 연계가 가능해져 서로 다른 부서 간의 원활한 정보 공유를 실현하고 있습니다. 이러한 연결성을 통해 의료진과 검사 결과를 실시간으로 공유할 수 있어, 특히 시간이 중요한 응급상황에서 임상적 판단 과정을 신속하게 처리할 수 있습니다. 또한, 인공지능(AI)과 머신러닝 알고리즘의 개발이 진행되고 있으며, 방대한 데이터세트에서 학습을 통해 기존에는 놓치기 쉬운 희귀 항체를 예측 및 검출하는 능력을 향상시켜 분석기의 정확도를 더욱 높이고 있습니다.

또 다른 큰 흐름은 면역혈액학 시스템의 소형화이며, 이로 인해 더 많은 환경에서 현장 진료 검사가 현실화되고 있습니다. 미세유체 기술을 탑재한 휴대용 분석기가 도입되어 원격지나 자원이 제한된 환경에서도 신속한 현장 혈액검사가 가능해졌습니다. 이러한 발전은 면역혈액학 검사의 접근성과 속도를 획기적으로 향상시켜, 필요한 시점에 필요한 곳에서 필요한 만큼의 고품질, 신뢰할 수 있는 진단을 제공할 수 있게 되었습니다. 기술의 진화가 계속되는 가운데, 면역혈액학 분석기는 임상 검사 의학의 변화에 필수적인 역할을 하며, 보다 효율적이고 정확하며 신속한 의료 시스템을 실현할 것입니다.

면역혈액학 분석기 및 시약 시장의 성장을 이끄는 요인은 무엇인가?

면역혈액학 분석기 및 시약 시장의 성장은 몇 가지 중요한 요인에 의해 주도되고 있으며, 각 요인은 이러한 기술에 대한 수요 증가에 기여하고 있습니다. 주요 촉진요인 중 하나는 전 세계적으로 수혈의 필요성이 증가하고 있다는 점입니다. 고령화, 암, 빈혈 등 만성질환의 확산, 복잡한 수술의 증가에 따라 안전하고 적합한 혈액제제에 대한 수요는 계속 확대되고 있습니다. 면역혈액학 분석기는 신속하고 정확한 혈액형 판정 및 항체 스크리닝을 제공하여 수혈의 안전성을 보장하며, 전 세계 병원, 혈액은행, 진료소에서 도입을 촉진하고 있습니다.

또 다른 중요한 요인은 임상 실험실에서 자동화의 중요성이 커지고 있다는 점입니다. 검사실에서는 더 많은 검사량을 처리하면서 더 빠르고 정확한 결과를 제공해야 한다는 압박이 커지면서 현대 면역혈액학 분석기의 자동화 기능은 필수적인 요소로 자리 잡았습니다. 이러한 시스템은 수작업을 줄이고 인적 오류를 최소화할 뿐만 아니라, 현대 의료 환경의 요구에 부응하는 연속적인 고처리량 검사를 가능하게 합니다. 이러한 추세는 대규모 혈액검사가 일상적으로 필요한 의료 인프라가 잘 갖춰진 선진국에서 특히 두드러집니다.

면역혈액학 시약의 기술 발전도 시장 성장에 기여하고 있습니다. 보다 특이적이고 민감하고 안정적인 시약의 개발로 혈액 검사 성능이 향상되어 희귀 항체 및 항원의 검출 정확도가 향상되었습니다. 이러한 혁신으로 면역혈액학 검사의 유용성은 일상적인 검사뿐만 아니라 자가면역질환 및 희귀 혈액형과 관련된 복잡한 사례에서도 확대되고 있습니다. 또한, 맞춤형 의료의 부상과 정밀 진단에 대한 관심이 높아지면서 첨단 면역혈액학 기술의 수요를 견인하고 있습니다. 이러한 기술은 개별화된 치료 계획에 필요한 상세한 분자 수준의 지식을 제공합니다.

마지막으로, 안전한 수혈의 중요성에 대한 규제적 지원과 대중의 인식이 높아진 것도 시장 확대에 기여하고 있습니다. 정부와 의료기관은 수혈의 안전성을 높이기 위해 엄격한 가이드라인과 노력을 기울이고 있으며, 이는 면역혈액학 분석기 및 시약의 도입률 향상으로 이어지고 있습니다. 이러한 추세가 지속되는 가운데, 점점 더 복잡해지는 의료 환경에서 자동화된 고정밀 혈액 검사에 대한 수요가 증가함에 따라 면역혈액학 시장은 큰 폭의 성장이 예상됩니다.

부문:

제품별(시약, 분석 기기), 기술별(중합효소 연쇄 반응, 겔카드, 바이오칩, 적혈구자화법, 마이크로플레이트), 용도별(병원, 진단/참고검사실, 혈액은행, 학술/연구기관)

조사 대상 기업 예시

  • Immucor, Inc.
  • Merck & Co., Inc.
  • Merck KgaA
  • Ortho Clinical Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Grifols SA

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Market Glass, Inc.는 LLM이나 산업 특화형 SLM을 조회하는 일반적인 방식이 아닌, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색 엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

Market Glass, Inc.가 본사 소재지, 생산기지, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측하는 가운데, 이번 보고서에서는 지리적 시장에 대한 관세의 영향을 반영하였습니다. 이러한 복잡하고 다면적인 시장 현실은 매출원가(COGS) 증가, 수익성 하락, 공급망 재편 등 경쟁사에게 다양한 영향을 미치며, 미시적 및 거시적 시장 역학에도 영향을 미칩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 세계 기타 지역

제4장 경쟁

KSM 25.12.18

Global Immunohematology Analyzers and Reagents Market to Reach US$3.3 Billion by 2030

The global market for Immunohematology Analyzers and Reagents estimated at US$2.5 Billion in the year 2024, is expected to reach US$3.3 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the Analyzers segment is estimated at 5.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$678.8 Million While China is Forecast to Grow at 4.5% CAGR

The Immunohematology Analyzers and Reagents market in the U.S. is estimated at US$678.8 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$519.0 Million by the year 2030 trailing a CAGR of 4.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.7% CAGR.

Global Immunohematology Analyzers and Reagents Market - Key Trends and Drivers Summarized

How Do Immunohematology Analyzers and Reagents Work to Ensure Safe Blood Transfusions?

Immunohematology analyzers and reagents are vital in the field of transfusion medicine, playing a central role in ensuring the safety and compatibility of blood transfusions. These sophisticated devices and chemicals are used to test blood samples for key markers, such as blood type, Rh factor, and the presence of specific antibodies that could cause adverse reactions during transfusions. Blood typing, for example, is crucial in matching donors and recipients. Immunohematology analyzers automate this process, detecting and identifying antigens (like A, B, and RhD) on the surface of red blood cells, helping medical teams to accurately determine the compatibility between donated blood and the recipient's immune system.

In addition to blood typing, immunohematology reagents are used to identify irregular antibodies that can form due to previous transfusions, pregnancy, or autoimmune conditions. These antibodies can cause hemolytic reactions if not detected before a transfusion, where the body attacks transfused red blood cells, potentially leading to life-threatening complications. Through advanced immunological techniques like agglutination, enzyme-linked immunosorbent assays (ELISA), and microcolumn gel technology, analyzers can precisely identify even low levels of these antibodies. By providing fast, accurate, and automated testing, immunohematology analyzers and reagents ensure the safety and success of blood transfusions, ultimately saving lives in both emergency and routine clinical settings.

Why Are Immunohematology Analyzers and Reagents Crucial in Disease Detection and Blood Management?

Immunohematology analyzers and reagents go far beyond transfusion safety-they are also essential in diagnosing blood-related disorders and managing diseases that affect the immune and hematologic systems. One of the most critical applications is in the detection and management of hemolytic diseases of the newborn (HDN), where a mother's antibodies attack the fetus’s red blood cells, leading to anemia and other complications. Through the use of specialized immunohematology reagents, healthcare professionals can detect anti-D antibodies and other relevant markers, allowing for early intervention and treatment, such as administering Rh immunoglobulin to prevent HDN.

Immunohematology technologies also play a pivotal role in managing autoimmune hemolytic anemia, a condition where the immune system mistakenly destroys red blood cells. By identifying autoantibodies that are attacking the patient’s blood, these systems help guide appropriate treatment, such as immunosuppressive therapy or the administration of compatible blood transfusions. Furthermore, in complex medical procedures like bone marrow transplants, accurate blood matching facilitated by these analyzers is crucial to avoid graft-versus-host disease, where the transplanted cells may attack the host’s body.

Additionally, immunohematology reagents are used to monitor patients undergoing long-term therapies, such as those with chronic anemia or cancer patients receiving chemotherapy, where regular blood testing is necessary to assess immune function and overall blood health. The automation provided by immunohematology analyzers ensures high-throughput, precise results that are critical for ongoing disease management. As the complexity of immunological and hematological conditions continues to grow, these systems provide indispensable tools for clinicians, helping to diagnose, monitor, and manage a wide array of blood disorders effectively.

How Are Immunohematology Analyzers Driving Technological Innovation in Laboratories?

Immunohematology analyzers are at the forefront of laboratory automation, revolutionizing the way blood banks and clinical labs operate by streamlining workflows and increasing testing accuracy. One of the key advancements in this field is the integration of automation and robotics within immunohematology systems, allowing for high-throughput processing of blood samples. Modern analyzers can process hundreds of samples per day with minimal human intervention, reducing the risk of human error and ensuring standardized testing procedures. This is especially important in large hospitals and blood banks where the demand for blood products is constant, and rapid, reliable results are critical for patient care.

The incorporation of advanced software and data management tools into immunohematology analyzers has also transformed laboratory efficiency. These systems are now capable of integrating with hospital information systems (HIS) and laboratory information management systems (LIMS), allowing for seamless communication between different departments. This connectivity enables real-time sharing of test results with healthcare providers, speeding up clinical decision-making processes, particularly in emergencies where time is of the essence. Additionally, artificial intelligence and machine learning algorithms are being developed to further enhance the precision of these analyzers, by learning from vast datasets to predict and detect rare antibodies that might otherwise go unnoticed.

Another major trend is the miniaturization of immunohematology systems, making point-of-care testing a reality in more settings. Portable analyzers equipped with microfluidic technologies are being introduced, enabling fast, on-site blood testing even in remote or resource-limited environments. These advances are drastically improving the accessibility and speed of immunohematology testing, ensuring that high-quality, reliable diagnostics are available where and when they are needed. As technology continues to evolve, immunohematology analyzers will remain integral to the transformation of laboratory medicine, leading to more efficient, accurate, and responsive healthcare systems.

What’s Driving the Growth in the Immunohematology Analyzer and Reagent Market?

The growth in the immunohematology analyzer and reagent market is driven by several critical factors, each contributing to the increasing demand for these technologies. One of the primary drivers is the rising need for blood transfusions globally. With an aging population, the prevalence of chronic diseases, such as cancer and anemia, and an increasing number of complex surgeries, the demand for safe and compatible blood products continues to grow. Immunohematology analyzers ensure that blood transfusions are safe by providing rapid and accurate blood typing and antibody screening, which has fueled their adoption across hospitals, blood banks, and clinics worldwide.

Another significant factor is the growing emphasis on automation in clinical laboratories. As labs face increasing pressure to deliver faster, more accurate results while managing higher volumes of tests, the automation capabilities of modern immunohematology analyzers are becoming indispensable. These systems not only reduce manual labor and minimize human error but also allow for continuous, high-throughput testing that meets the demands of modern healthcare environments. This trend is particularly evident in developed countries with well-established healthcare infrastructures, where large-scale blood testing is a daily requirement.

Technological advancements in immunohematology reagents are also contributing to market growth. The development of more specific, sensitive, and stable reagents has enhanced the performance of blood tests, leading to improved detection of rare antibodies and antigens. These innovations have expanded the utility of immunohematology assays in both routine testing and complex cases, such as those involving autoimmune disorders or rare blood types. Furthermore, the rise of personalized medicine and the increasing focus on precision diagnostics are driving demand for advanced immunohematology technologies, which offer the detailed molecular insights needed for tailored treatment plans.

Finally, regulatory support and increasing public awareness about the importance of safe blood transfusions have also played a role in market expansion. Governments and healthcare organizations are implementing stringent guidelines and initiatives to improve transfusion safety, which has led to higher adoption rates of immunohematology analyzers and reagents. As these trends continue, the immunohematology market is poised for substantial growth, driven by the rising need for automated, high-precision blood testing in an increasingly complex healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Immunohematology Analyzers and Reagents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents, Analyzers); Technology (Polymerase Chain Reaction, Gel Cards, Biochips, Erythrocyte-Magnetized, Microplates); End-Use (Hospitals, Diagnostic & Reference Laboratories, Blood Banks, Academic & Research Institutes)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 12 Featured) -

  • Immucor, Inc.
  • Merck & Co., Inc.
  • Merck KgaA
  • Ortho Clinical Diagnostics
  • Siemens Healthineers
  • Thermo Fisher Scientific, Inc.
  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Grifols SA

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Immunohematology Analyzers and Reagents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Blood Transfusions Drives Growth in Immunohematology Analyzers and Reagents Market
    • Expansion of Blood Bank Services Spurs Adoption of Immunohematology Analyzers
    • Increasing Focus on Fully Automated and High-throughput Immunohematology Analyzers Fuels Market Demand
    • Growth in Use of Immunohematology in Crossmatching and Compatibility Testing Expands Market Opportunities
    • Growth in Demand for Immunohematology Analyzers in Hospital Laboratories Fuels Market Expansion
    • Increasing Focus on Immunohematology for Rare Blood Group Detection Expands Addressable Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Immunohematology Analyzers and Reagents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Immunohematology Analyzers and Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Immunohematology Analyzers and Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Polymerase Chain Reaction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Polymerase Chain Reaction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Gel cards by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Gel cards by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Gel cards by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Erythrocyte-Magnetized by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Erythrocyte-Magnetized by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Erythrocyte-Magnetized by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Microplates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Microplates by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Microplates by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic & Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic & Reference Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Diagnostic & Reference Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Blood Banks by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Blood Banks by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Academic & Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Academic & Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • JAPAN
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • CHINA
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • EUROPE
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Immunohematology Analyzers and Reagents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • FRANCE
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • GERMANY
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Europe Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Europe Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Europe 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Immunohematology Analyzers and Reagents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Asia-Pacific Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Asia-Pacific 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Asia-Pacific Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Asia-Pacific 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Asia-Pacific 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 140: Rest of World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of World Historic Review for Immunohematology Analyzers and Reagents by Product - Reagents and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of World 15-Year Perspective for Immunohematology Analyzers and Reagents by Product - Percentage Breakdown of Value Sales for Reagents and Analyzers for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of World Historic Review for Immunohematology Analyzers and Reagents by Technology - Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of World 15-Year Perspective for Immunohematology Analyzers and Reagents by Technology - Percentage Breakdown of Value Sales for Polymerase Chain Reaction, Gel cards, Biochips, Erythrocyte-Magnetized and Microplates for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World Historic Review for Immunohematology Analyzers and Reagents by End-Use - Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of World 15-Year Perspective for Immunohematology Analyzers and Reagents by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic & Reference Laboratories, Blood Banks and Academic & Research Institutes for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제